Healthcare -
Biotechnology - NASDAQ - US
$ 7.5892
2.42 %
$ 643 M
Market Cap
-3.09
P/E
VERV - CHANGE IN WORKING CAPITAL
Change in Working Capital VERV - Verve Therapeutics, Inc.
17.7 M
LAST VALUE
184.24%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR